Occult persistence and lymphotropism of hepadnaviral infection: Insights from the woodchuck viral hepatitis model

Immunological Reviews

Volumn 174, Issue , 2000, Pages 98-111

  Michalak, Tomasz I ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA;

ADOLESCENT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL HEPATITIS; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; CHRONIC LIVER DISEASE; CONVALESCENCE; DISEASE MODEL; HEPADNAVIRUS; HEPATITIS B; HEPATITIS B VIRUS; INFECTION COMPLICATION; LIVER BIOPSY; LYMPHATIC SYSTEM; LYMPHOID CELL; LYMPHOID TISSUE; MONONUCLEAR CELL; NEWBORN; NONHUMAN; PERSISTENT VIRUS INFECTION; PLACENTAL TRANSFER; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; VIRUS CARRIER; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION; WOODCHUCK;

ANIMALS; ANIMALS, NEWBORN; CARRIER STATE; CELLS, CULTURED; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS, WOODCHUCK; HEPATITIS, VIRAL, ANIMAL; HUMANS; LIVER; LYMPHOCYTES; LYMPHOID TISSUE; MARMOTA; ORGAN SPECIFICITY; VIRUS LATENCY;

EID: 0034083575     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.017406.x     Document Type: Review

References (66)

1. 1. Summers J, Smolec JM, Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 1978;354:371-378.
2. 2. Galibert F, Chen T-N, Mandart E. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol 1982;41:51-65.
3. 3. Frommel D, et al. Immunopathological aspects of woodchuck hepatitis. Am J Pathol 1984;115:125-134.
4. 4. Millman I, Southam L, Halbherr T, Simmons H, Kang CM. Woodchuck hepatitis virus: experimental infection and natural occurrence. Hepatology 1984;4:817-823.
5. 5. Korba BE, Wells F, Tennant BC, Yoakum GH, Purcell RH, Gerin JL. Hepadnavirus infection of peripheral blood lymphocytes in vivo: woodchuck and chimpanzee models of viral hepatitis. J Virol 1986;58:1-8.
6. 6. Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL. Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 1987;84:866-870.
7. 7. Korba BE, et al. Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues. J Virol 1989;63:1360-1370.
8. 8. Tennant BC, Gerin JL. The woodchuck model of hepatitis B virus infection. In: Arias IM, Boyer JL, Fajusto N, Jakoby WB, Schachter DA, Shafritz DA, eds. The liver: biology and pathobiology. 3rd ed. New York: Raven Press; 1994. p. 1455-1466.
9. 9. Buendia MA. Hepatitis B viruses and liver cancer: the woodchuck model. In: Mason A, Neil J, McCrea M, eds. Viruses and cancer. Cambridge: University Press; 1994. p.193-197.
10. 10. Michalak TI. The woodchuck animal model of hepatitis B. Viral Hepatitis Rev 1998;4:139-165.
11. 11. Romet-Lemonne J-L, McLane MF, Elfassi E, Haseltine WA, Azocar J, Essex M. Hepatitis B virus infection in cultured human lymphoblastoid cells. Science 1983;221:667-669.
12. 12. Pontisso P, Poon M V, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in mononuclear cells. Br Med J 1984;288:1563-1566.
13. 13. Laure F, Zagury D, Saimot AG, Gallo RC, Hahn BH, Brechot C. Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS-related complex. Science 1985;229:561-563.
14. 14. Pasquinelli C, et al. Hepatitis B virus infection of peripheral blood mononuclear cells is common in acute and chronic hepatitis. J Med Virol 1990;31:135-140.
15. 15. Mason A, et al. Hepatitis B virus DNA in peripheral blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology 1992;16:36-41.
16. 16. Pardoe IU, Michalak TI. Detection of hepatitis B and woodchuck hepatitis viral DNA in plasma and mononuclear cells from heparinized blood by the polymerase chain reaction. J Virol Methods 1995;51:277-288.
17. 17. Stoll-Becker S, et al. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol 1997;71:5399-5407.
18. 18. Laskus T, Radkowski M, Wang L-F, Nowicki M, Rakela J. Detection and sequence analysis of hepatitis B virus integration in peripheral blood mononuclear cells. J Virol 1999;73:1235-1238.
19. 19. Chemin I, et al. Selective detection of human hepatitis B surface and core antigens in peripheral blood mononuclear cells subsets by flow cytometry. J Viral Hepat 1994;1:39-44.
20. 20. Korba BE, Wells F, Tennant BC, Cote JP, Gerin JL. Lymphoid cells in the spleens of woodchuck hepatitis virus-infected woodchucks are a site of active viral replication. J Virol 1987;61:1318-1324.
21. 21. Ogston CW, Schechter EM, Humes CA, Pranikoff MB. Extrahepatic replication of woodchuck hepatitis virus in chronic infection. Virology 1989;169:9-14.
22. 22. Gerin JL, Cote PJ, Korba BE, Miller RH, Purcell RH, Tennant BC. The woodchuck as an experimental model of hepadnavirus-induced liver cancer. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease. Baltimore: Williams and Wilkins; 1991. p. 556-559.
23. 23. Korba BE, Cote PJ, Gerin JL. Mitogen-induced replication of woodchuck hepatitis virus in cultured peripheral blood lymphocytes. Science 1988;241:1213-1216.
24. 24. Michalak TI, et al. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999;29:928-938.
25. 25. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994;93:230-239.
26. 26. Rehermann B, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995;181:1047-1058.
27. 27. Penna A, et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996;98:1185-1194.
28. 28. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996;2:1104-1108.
29. 29. Yotsuyanagi H, et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1998;27:1377-1382.
30. 30. Coffin CS, Michalak TI. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J Clin Invest 1999;104:203-212.
31. 31. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84-92.
32. 32. Blum HE, Offensperger W-B, Walter E, Offensperger S, Gerok W. Latent hepatitis B virus infection with full-length viral genome in a patient serologically immune to hepatitis B virus infection. Liver 1988;8:307-316.
33. 33. Blum HE, Liang TJ, Galum E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991;14:56-63.
34. 34. Brechot C, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985;312:270-276.
35. 35. Thiers V, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988;2:1273-1276.
36. 36. Liang TJ, Blum HE, Wands JR. Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology 1990;15:32-36.
37. 37. Larsen J, Hetland G, Skaug K. Post-transfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 1990;30:431-432.
38. 38. Sánchez-Quijano A, et al. Hepatitis B virus occult infection in subjects with persistent isolated anti-WHc reactivity. J Hepatol 1993;17:288-293.
39. 39. Chazouillères O, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343:142-146.
40. 40. Lowell JA, et al. Serological evidence of past hepatitis B infection in liver donors and hepatitis B infection in liver allografts. Lancet 1995;345:1084-1085.
41. - organ donors. Transplantation 1995;59:230-234.
42. 42. Uemoto S, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998;65:494-499.
43. 43. McIvor C, Morton J, Bryant A, Cooksley WG, Durrant S, Walker N. Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Ann Intern Med 1994;121:274-275.
44. 44. Martin P, Friedman LS. Chronic viral hepatitis and the management of chronic renal failure. Kidney Int 1995;47:1231-1241.
45. 45. Carman WF, Dourakis S, Karayiannis P, Crossey M, Drobner R, Thomas HC. Incidence of hepatitis B viraemia, detected using the polymerase chain reaction, after successful therapy of hepatitis B virus carriers with interferon-α. J Med Virol 1991;34:114-118.
46. 46. Kuhns M, McNamara S, Mason A, Campbell C, Perrillo R. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 1992;103:1649-1656.
47. 47. Loriot M-A, et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 1997;27:251-258.
48. 48. Paterlini P, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323:80-85.
49. 49. Lai MY, et al. Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology 1990;12:575-581.
50. 50. Kamito H, et al. Detection of hepatitis B virus genome in hepatocellular carcinoma from both hepatitis B surface antigen-and antibody to hepatitis C virus-negative patients: a study using polymerase chain reaction. Oncol Rep 1996;3:619-623.
51. 51. Zhang YY, Hansson BG, Kuo LS, Widell A, Nordenelt E. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg Hepatology 1993;17:538-544.
52. 52. Michalak TI, Snyder RL, Churchill ND. Characterization of the incorporation of woodchuck hepatitis virus surface antigen into hepatocyte plasma membrane in woodchuck hepatitis and in the virus-induced hepatocellular carcinoma. Hepatology 1989;10:44-55.
53. 53. Seeger C, et al. Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host. J Virol 1991;65:1673-1679.
54. 54. Jin Y-M, Churchill ND, Michalak TI. Protease-activated lymphoid cell and hepatocyte recognition site in the preS1 domain of the large woodchuck hepatitis virus envelope protein. J Gen Virol 1996;77:1837-1846.
55. 55. Shimìzu H, Mitsuda T, Fujita S, Yokota S. Perinatal hepatitis B virus infection caused by antihepatitis B positive maternal mononuclear cells. Arch Dis Child 1991;66:718-721.
56. 56. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MBA. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. J Exp Med 1984;60:521-540.
57. 57. Ahmed R, Oldstone MBA. Organ-specific selection of viral variants during chronic infection. J Exp Med 1988;167:1719-1724.
58. 58. Matloubian M, Kolhekar SR, Somasundaram T, Ahmed R. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J Virol 1993;67:7340-7349.
59. 59. Michalak TI, Desousa JRB, Churchill ND, Rangraju NS, Ananthanarayanan VS. Host and organ specific recognition site within preS1-encoded sequence of woodchuck hepatitis virus envelope. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease. Baltimore: Williams and Wilkins; 1991. p. 262-266.
60. 60. Klenk H-D, Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol 1994;2:39-43.
61. 61. Diao J, Churchill ND, Michalak TI. Complement mediated cytotoxicity and inhibition of ligand binding to hepatocytes by woodchuck hepatitis virus-induced autoantibodies to asialoglycoprotein receptor. Hepatology 1998;27:1623-1631.
62. 62. Oldstone MB. Virus-lymphoid cell interactions. Proc Natl Acad Sci USA 1996;93:12756-12758.
63. 63. Guidotti LG, Chisari FV. To kill or to cure: opinions in host defense against viral infection. Curr Opin Immunol 1996;8:478-483.
64. 64. Oldstone MB. How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. Virology 1997;234:179-185.
65. 65. Ahmed R, Morrison LA, Knipe DM. Viral persistence. In: Ahmed R, Gonzalez-Scarano F, Griffin DE, Holmes KV, Murphy FA, Robinson HL, eds. Viral pathogenesis. Philadelphia: Lippincott-Raven Publishers; 1997. p. 181-205.
66. 66. Klenerman P, Zinkernagel RM. What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus? Immunol Rev 1997;159:5-16.